Organon & Co | OGN - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Celltrion KRW 104.19B 15.67B 2025-09
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 9.72M 3.02M 2025-12
Divis Laboratories Ltd INR 10.4B 1.3B 2025-09
Gilead Sciences USD 808M 226M 2025-09
Glaxosmithkline GBP 20.72B 346.14M 2025-12
Kangmei Pharma CNY 2.61B 176.42M 2025-09
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Merck USD 4.15B 102M 2025-09
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Novartis USD 4.46B 99M 2025-12
Organigram Holdings CAD 71.08M 18.17M 2025-12
Organon & Co USD 1.07B 7M 2025-09
Ovoca Bio EUR 186K 23K 2025-06
Pharma Mar EUR 54.34M 10.54M 2025-12
Qiagen NV USD 72.66M 2.11M 2025-12
Sartorius EUR 323.2M 61M 2025-09
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Tilray USD 114.5M 3.69M 2025-09
Zealand Pharma A/S 346.6M 102.71M 2025-12